| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/01/2004 | EP1451368A2 Single nucleotide polymorphisms in gh-1 |
| 09/01/2004 | EP1451367A2 Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| 09/01/2004 | EP1451343A2 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof |
| 09/01/2004 | EP1451341A2 Eit-6, a polypeptide encoded by an estrogen regulated gene |
| 09/01/2004 | EP1451337A2 Nogo receptor-mediated blockade of axonal growth |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451329A2 Genetic vaccine against human immunodeficiency virus |
| 09/01/2004 | EP1451327A2 Compositions from the grasses lolium perenne and festuca arundinacea |
| 09/01/2004 | EP1451325A2 Transcription factor stress-related polypeptides and methods of use in plants |
| 09/01/2004 | EP1451324A2 G-protein coupled receptor lustr2 and uses thereof |
| 09/01/2004 | EP1451323A2 Pharmaceutical compositions of marine sponge microciona prolifera |
| 09/01/2004 | EP1451322A2 Il-21 antagonists |
| 09/01/2004 | EP1451321A1 A method of genetic screening using an amplifiable gene |
| 09/01/2004 | EP1451315A2 Human coagulation factor vii polypeptides |
| 09/01/2004 | EP1451309A2 Love variant regulator molecules |
| 09/01/2004 | EP1451307A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/01/2004 | EP1451305A2 Epitope synchronization in antigen presenting cells |
| 09/01/2004 | EP1451297A1 Phenotypic screen of chimeric proteins |
| 09/01/2004 | EP1451296A2 Expression of polypeptides in rod outer segment membranes |
| 09/01/2004 | EP1451293A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 09/01/2004 | EP1451292A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted |
| 09/01/2004 | EP1451291A2 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
| 09/01/2004 | EP1451225A1 Agonists of recombinant human histamine h3 receptor |
| 09/01/2004 | EP1451224A2 Peptide or protein containing a c'-d loop of the cd28 receptor family |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451221A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 09/01/2004 | EP1451220A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 09/01/2004 | EP1451219A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 09/01/2004 | EP1451217A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| 09/01/2004 | EP1451216A1 Immunointeractive molecules and uses thereof |
| 09/01/2004 | EP1451215A2 Method to isolate genes involved in aging |
| 09/01/2004 | EP1451214A2 Protein-protein interactions in human immunodeficiency virus |
| 09/01/2004 | EP1451213A2 Human and murine cytokine polypeptides |
| 09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
| 09/01/2004 | EP1451207A2 Labeling reagent and methods of use |
| 09/01/2004 | EP1451201A2 Nucleotide analogues and their use for nucleic acid sequencing |
| 09/01/2004 | EP1451193A1 Podophyllotoxins as antiproliferative agents |
| 09/01/2004 | EP1450872A1 Composition and method for treatment of wounds |
| 09/01/2004 | EP1450857A2 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/01/2004 | EP1450856A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 09/01/2004 | EP1450855A2 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 09/01/2004 | EP1450850A1 Method of administering a thymosin alpha 1 peptide |
| 09/01/2004 | EP1450846A2 Self-assembling polymers, and materials fabricated therefrom |
| 09/01/2004 | EP1450845A2 15603, a human ion channel family member |
| 09/01/2004 | EP1450828A2 In situ immunization |
| 09/01/2004 | EP1450752A2 Multivalent streptococcal vaccine compositions and methods for use |
| 09/01/2004 | EP1450605A2 A composition and method to alter lean body mass and bone properties in a subject |
| 09/01/2004 | EP1303534A4 Promyostatin peptides and methods of using same |
| 09/01/2004 | EP1218411A4 Secreted proteins and uses thereof |
| 09/01/2004 | EP1165135B1 Methods of screening for compounds modulating fxr receptors |
| 09/01/2004 | EP0975764B1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 09/01/2004 | EP0973908B1 Plants with controlled side-shoot formation and/or controlled abscission area formation |
| 09/01/2004 | EP0941369B1 Dna for evaluating the progression potential of cervical lesions |
| 09/01/2004 | EP0808630B1 Cancer control |
| 09/01/2004 | EP0772627B1 Production of biologically active recombinant neurotrophic protein |
| 09/01/2004 | EP0769057B1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 09/01/2004 | EP0764172B1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 09/01/2004 | EP0753011B1 Thymidine kinase tk1, peptide, corresponding antibodies and use of these in determination of tumor proliferation |
| 09/01/2004 | EP0728141B1 A method for identifying anti-parasitic compounds |
| 09/01/2004 | EP0700442B1 Immortalized human cell lines containing exogenous cytochrome p450 genes |
| 09/01/2004 | EP0634936B1 Methods for immunocontraception |
| 09/01/2004 | EP0616640B1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 09/01/2004 | CN1526072A Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 09/01/2004 | CN1526021A Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1526014A Paramyxovirus vectors for introducing foreign genes into skeletal muscle |
| 09/01/2004 | CN1526012A A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
| 09/01/2004 | CN1526010A Bacterial host strains |
| 09/01/2004 | CN1525981A T1R taste receptors and genes encoding same |
| 09/01/2004 | CN1525977A Purification of human serum albumin |
| 09/01/2004 | CN1525869A Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 09/01/2004 | CN1525868A Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 09/01/2004 | CN1525866A Treatment using neublastin polypeptides |
| 09/01/2004 | CN1525864A Mucin peptide with immunoenhancing properties |
| 09/01/2004 | CN1525168A Methods of detecting alzheimer's disease |
| 09/01/2004 | CN1524959A Method for producing gene engineering recombination 192 peptide human growth hormone |
| 09/01/2004 | CN1524958A Angiotensin II correlative gene, coding protein and application thereof |
| 09/01/2004 | CN1524950A Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof |
| 09/01/2004 | CN1524881A Nanometer metallothionin and preparing process thereof |
| 09/01/2004 | CN1524880A Protein cross linking agent and method therefor |
| 09/01/2004 | CN1524879A Anti endothelial cell element, genes encoding same and pharmaceutical uses thereof |
| 09/01/2004 | CN1524878A Immunization magnetic separation technology for purifying genetic engineering recombinant interferon |
| 09/01/2004 | CN1524877A Construction and preparation of stroma cell derivative factor - 1ª‡ recombinant mutant |
| 09/01/2004 | CN1524876A Na+/h+ counter rotatable protein of salicornia europaeal , genes encoding same and use thereof |
| 09/01/2004 | CN1524875A Nuclear stromatin combination sequence and application thereof |
| 09/01/2004 | CN1524874A E1A protein, its preparing process and combination of medicament comprising the protein |
| 09/01/2004 | CN1524873A Method of manufacturing t-20 and t-1249 peptides at commercial scale, and t-20 and t-1249 compositions related thereto |
| 09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164753C Fusion protein of type IV collagenase resistant single chain antibody and Lidamycin agon protein |
| 09/01/2004 | CN1164615C Production process of ferric caseinate |
| 09/01/2004 | CN1164614C Memory clearing protein and its application |
| 09/01/2004 | CN1164613C Simple high-density lipoprotein separating process from serum and the preparation of its subcomponent reagent kit |
| 09/01/2004 | CN1164612C Artificial combined antibacterial engineering polypeptide and its preparation method |
| 09/01/2004 | CN1164606C Gene of 26S proteinase alpha subunit for regulating degradation of mouseearcress abnormal protein |
| 09/01/2004 | CN1164332C Preparation method of horse SARS-resisting serum |